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 Transesophageal echocardiography was performed to as-
sess the incidence of left atrial spontaneous echo contrast 
in patients with hypertrophic cardiomyopathy, who were di-
vided into two groups according to the presence (group 1-A; 
10 patients) or absence (group 1-B; 5 patients) of persistent 
atrial fibrillation. Twelve patients with atrial fibrillation 
(group 2) served as control. Among these, 5 patients had 
mitral regurgitation and 8 patients lone atrial fibrillation. 
Left atrial spontaneous echo contrast was detected in 8 pa-
tients (80%) in group 1-A, none in group 1-B, and 3 pa-
tients (25%) in group 2. The incidence of echo contrast in 
group 1-A was significantly higher than that in the other 
2 groups. The size of the left atrium was not statistically 
different among the 3 groups. Accordingly, hypertrophic 
cardiomyopathy with atrial fibrillation seemed to be a spe-
cific diseased state to favor the development of the left 
atrial spontaneous echo contrast. Previous reports suggested 
that the presence of left atrial spontaneous contrast was 
considered as a warning sign of left atrial thrombus and 
would be an indicator of increased risk of embolism. 1)2)3) Three 
of the 8 patients who had spontaneous echo contrast in group 
1-A had a history of systemic embolization. We proposed 
that patients with hypertrophic cardiomyopathy with atrial 
fibrillation were in a high risk state of thromboembolism.
Introduction
  Transesophageal echocardiography provides superior 
imaging of the left atrium and has been clinically ap-
plied as a diagnostic method for detection of the source 
of embolism."') 5) 
 Recently, left atrial spontaneous echo contrast (LASEC) 
which represents the status of left atrial blood flow 
has been recognized as a risk factor for thrombus and 
embolization.)2) Many investigators suggest that mitral 
stenosis, atrial fibrillation and large left atrium are con-
sidered major factors to develop LASEC. In addition, 
remarkable LASEC in hypertrophic cardiomyopathy 
(HCM) has sometimes drawn our attention (Fig 1). 
However, to the best of our knowledge, no previous re-
ports have presented the relation between HCM and 
LASEC. Therefore, this study was prospectively de-
signed to assess the incidence and severity of LASEC 
in patients with HCM. The history of systemic embo-
lism was also elaborately inquired.
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Fig. 1. Transesophageal echocardiogram. Left atrial sponta-
neous echo contrast is shown in transverse 4 chamber view 
in a case of hypertrophic cardiomyopathy with atrial fibrillation.
Methods
 Patient population: The study included 15 HCM pa-
tients, who were divided into two groups according to 
the presence (group 1-A) or absence (group 1-B) of 
persistent atrial fibrillation. The diagnosis of HCM was 
made in terms of asymmetrical septal hypertrophy, 
apical hypertrophy and/or diffuse increased LV wall 
thickness (15mm) associated with ECG changes com-
patible to HCM. Twelve atrial fibrillation patients 
without HCM served as control (group 2). 
 Group 1-A (HCM with atrial fibrillation) consisted 
of 10 patients, 4 women and 6 men, with the mean 
age of 61 year (range 54 to 70 years) (table 1). Group 
1-B (HCM with sinus rhythm) consisted of 5 patients, 
1 women and 4 men, with the mean age of 63 years 
(range 45 to 70 years) (table 1). Group 2 (control) 
consisted of 12 atrial fibrillation patients without HCM. 
In this group, transesophageal echocardiography was 
used to evaluate the severity of mitral regurgitation in
Table 1.
        HCM with Chronic Af No. :10 
               * LAd LVd EF IVS LVPW ** Stroke or 
Name Age-Sex SEC o MR Systemic                   (mm) (mm) (/o) (mm) (mm) 
embolism 
T H 54 M 3 58 23/54 90 16 15 - Renal                                                      infarction 
K I 70 M 3 49 32/49 73 16 12 - -
K 0 65 M 3 52 30/49 77 (1A3 1 ica  11 
                                   l type) +
M T 61 F 3 50 22/42 86 20 12 -}- -
M Y 56 F 3 40 23/44 86 18 13 - -
T K 62 M 2 39 26/42 76 14 15 - CVA 
S S 57 F - 43 24/38 75 25 12 ~- -
K M 68 F 3 46 23/34 70 17 13 - -
T K 64 M 3 45 31/49 75 15 12 - CVA 
M Y 57 M - 46 35/51 58 14 15 - -
    mean 47±5 27'4 77±9 17±3 13±1 * grade of LASEC 
                                                     ** mosaic area 
                                                        Z5.0cm2
      HCM with Sinus rhythm No :5 
               * LAd LVd EF IVS LVPW ** Stroke or 
Name Age-Sex SEC (mm) (mm) (%) (mm) (mm) MR Svstemic 
                                                                 embolism 
M N 66 F - 35 28/51 76 19 10 ~- -
K I 67 M - 47 22/48 90 18 15 - -
N K 45 M - 41 24/48 87 20 13 - -
  U 70 M - 44 25/49 86 18 13 - -
H I 67 M - 42 37/44 41 17 14 - -
    mean 42±4 27+ 76±18 18±1 13±2 * grade of LASEC 
                                                     ** mosaic area
                                                        k5.Ocm2
5 patients and to rule out the cardiac source of embo-
lism in 7 patients (three of them had a history of stroke 
or other systemic embolism). No patients with mitral 
stenosis were included. The age ranged from 48 to 81 
years with the mean of 71 years (table 2). The history 
of patients in the 3 groups was carefully inquired for 
unequivocally documented event of systemic embolization. 
At the time of study, 3 patients in group 1-A and 3 
patients in group 2 were receiving anticoagulant. In-
formed consent was obtained from each patient prior 
to entering this study.
Table 2.
              Chronic Af No.: 12 
                 LAd LVd EF IVS LVPW Heart * Stroke or Name Age Sex SEC 
(mm) (mm) (%) (mm) (mm) Disease Svstemic                                                              embolism 
T 0 73 M - 51 27/48 81 14 14 MR, TR -                                                       Pacemaker 
K S 75 M - 55 34/58 72 9 11 MR -
S I 80 F - 35 20/43 85 8 8 MR, AR -
K S 73 F - 42 30/49 76 11 12 H H D -
T I 58 M - 43 43/54 52 8 10 - CVA 
M K 71 M - 48 30/45 61 9 10 MR, TR -
A U 71 M - 58 32/60 78 12 12 MR, TR -
T M 81 M 3 45 35/53 71 11 10 - Femoral and                                                               BrachiS H 48  - 40 35/51 66111 2 - -
M M 64 M - 43 30/53 75 11 9 - -
T D 85 M 2 41 34/46 60 10 10 - -
T J 69 M 1 32 30/48 76 10 11 - -I-
     mean 44±7 32+51+5 71±9 10±2 11±1 *No MS included
 Echocardiography: Transthoracic echocardiography 
was performed in a standardized fashion by using a 3.75 
MHz probe. Left atrial diameter was obtained in the 
M-mode echocardiogram from the parasternal long axis 
view by the American Society of Echocardiography.') 
Transesophageal echocardiography was performed with 
a biplane (model PEF-507SB, Toshiba) 5 MHz probe in 
conjunction with Toshiba SSH-160A. Following local 
pharyngeal anesthesia with a topical lidocaine spray, 
the esophageal probe was introduced. There were no 
complications attributable to the procedure.
 Left atrial spontaneous echo contrast (LASEC) was 
defined as dynamic clouds of echoes curing slowly in 
a circular or spiral shape within the left atrial cavity. 
The characteristic swiring motion pattern was useful 
in differentiating white nose artifact usually located 
throughout the ultrasound field at a high gain setting. 
When the presence of LASEC was suspected, the gain 
setting was decreased in a stepwise fashion to exclude 
white nose artifact. On the basis of its appearance, 
LASEC was graded into 3 groups: grade 3 was defined 
as an intensive echo contrast easily recognized at a 
normal gain setting throughout the entire left atrium;
grade 2 as echo contrast clearly visible in some part 
of the left atrium in an ordinary gain setting; and 
grade 1 as faint echo contrast in small part of the left 
atrium in a relatively high gain setting. Mitral regurgi-
tation was defined as moderate to severe when the 
mosaic area in transesophageal echocardiography was 
above 5.0cm2, and mosaic area below 5.0cm2 was esti-
mated as mild or insignificant according to the previ-
ous reports."' 0 11 All echocardiograms were carefully 
evaluated by two independent observers.
significantly higher than that in group 1-B and group 
2 (fig 2). Left atrial thrombus was not observed in 
any patients in the 3 groups. Moderate to severe mitral 
regurgitation in transesophageal echocardiography was 
detected in 3, 1 and 5 patients in groups 1-A, 1-B and 
2, respectively. There were no significant differences in 
the incidence of mitral regurgitation among the 3 groups.
Results
 Left atrial spontaneous echo contrast (LASEC) was 
observed in 8 (80%) of the 10 patients in group 1-A, 
7 being classified as grade 3 and 1 patient as grade 2. 
Independent evaluation by the 2 observers resulted in 
only small discrepancies concerning the classification 
of LASEC. Three of these 10 patients (30%) had a 
history of documented arterial embolization to the 
brain and kidney, and LASEC was observed in all of 
them. No LASEC nor a history of arterial embolization 
was detected in any of the 5 patients in group 1-B 
(table 1). Three (25%) of the 12 patients in group 2 
had SEC (grade 1, grade 2 and grade 3 in 1 patient 
each) (table 2). Although 3 patients in group 2 had a 
history of arterial embolization, it was not referred to 
the incidence, because transesophageal echocardiogra-
phy was to exclude the source of embolism in those 3 
patients. The incidence of LASEC iri group 1-A was
Fig. 2. Incidence of left atrial spontaneous echo contrast in 
group 1-A, group 1-B and group2. 
LASEC = Left atrial spontaneous echo contrast
[LASEC (-F) :0 (-) :O ]
Fig. 3. Individual values for left atrial dimension and left ventricular ejection fraction in patients in group 1-A, group 1-B and group 2. 
LAd = Left atrial dimension LVEF = Left ventricular ejection fraction LASEC = Left atrial spontaneous echo contrast 
Closed circle indicates a patient with LASEC and open circle indicates a patient without LASEC.
 Transthoracic echocardiography revealed LASEC in 
none of the patients studied. Echocardiographic char-
acteristics are shown in table 1 and table 2. Left atrial 
dimension and left ventricular ejection fraction are 
also demonstrated in figure 3. Left atrial dimension 
was 47±5mm, 42±4mm and 44±7mm in group 1-A, 
group 1-B and group 2, respectively. The differences 
were not statistically significant among the 3 groups. 
Left ventricular ejection fraction was 77±8%, 76±18 
% and 71±9% in groups 1-A, 1-B and 2, respectively. 
There were no significant differences among the 3 
groups.
Discussion
 Left atrial spontaneous echo contrast (LASEC) is 
the smoke-like refractances of swiring blood in the left 
atrium seen in a low blood flow state and may predis-
pose to thrombus formation and systemic emboly."6' It 
is well known that LASEC is not a common finding 
by transthoracic echocardiography. Recently, the ad-
vent of transesophageal echocardiography made it pos-
sible explore the left atrium more precisely with a 
proximity of the probe to the left atrium and with the 
use of the higher frequency probe. 
 Hence, LASEC became a more frequent finding, espe-
cially in patients with mitral stenosis and atrial fibrilla-
tion.' Many previous reports concerning LASEC have 
only studied patients with mitral valvular disease.' )2) 
Little interest seems to have turned to hypertrophic 
cardiomyopathy (HCM) for its association with LASEC. 
Therefore, we evaluated the incidence of LASEC in pa-
tients with HCM prospectively. First, LASEC was 
found in 8 (80%) of 10 HCM patients with Af. On the 
other hand, LASEC was not detected in any HCM pa-
tients with sinus rhythm. Secondly, LASEC was identi-
fied in only 3 (25%) of the 12 atrial fibrillation pa-
tients without HCM. The incidence was significantly 
lower than that in HCM patients with atrial fibrilla-
tion. Previous reports have also shown only 16% of 
the patients with lone atrial fibrillation had LASEC.12' 
Accordingly, it seems that HCM might be an inde-
pendent diseased state to favor the development of 
LASEC. The limitation of this study was the clinical 
characteristics of the patients in group 2 used as con-
trol. Transesophageal echocardiogram was useful for 
evaluation of the severity of mitral regurgitation, mod-
erate to severe in 5 (42%) of the 12 patients. Previous 
reports suggested that the presence of significant mitral 
regurgitation would preclude the development of LASEC 
as well as left atrial thrombus because the static blood 
stirred by regurgitant flow increases the flow velocity
in the left atrium and eliminate blood stasis."' 13) M) In 
fact, 3 (43%) of 7 patients without mitral regurgita-
tion in group 2 had LASEC. However, 3 patients 
(30%) in group 1-A also had significant mitral regur-
gitation and LASEC was discovered in 2 of those 3 pa-
tients. The mechanism of the formation of LASEC still 
remains unknown. The lack of effective atrial contrac-
tion in patients with atrial fibrillation, disturbance of 
diastolic flow into the left ventricle in patients with 
mitral stenosis and large left atrial cavity have been 
recognized as the factors favoring stasis of left atrial 
blood.' 13) Although it was not the objective of the pre-
sent study to clarify the pathogenesis of LASEC in pa-
tients with HCM, some contributing factors were specu-
lated. The fundamental pathophysiological abnormalities 
in HCM are increased stiffness of the left ventricle 
with resultant impaired ventricular filling."' Left ven-
tricular diastolic dysfunction causes elevation of left 
ventricular diastolic pressure and left atrial pressure. 
Accordingly, in addition to the alteration of flow pat-
tern into the left ventricle in distole, pulmonary vein 
flow and left atrial appendage flow may also be al-
tered, especially under the condition of atrial fibrilla-
tion. Previous reports indicate the pulmonary vein flow 
pattern in patients with atrial fibrillation differed from 
normal in that systolic flow velocity was blunt.`' On 
the other hand, diastolic pulmonary vein flow was re-
ported to decrease in HCM patients with sinus rhythm 
.1" Consequently, the left atrial flow pattern in HCM 
patient with atrial fibrillation may become indolent 
throughout the cardiac cycle, which may contribute to 
the formation of LASEC. 
 Spontaneous echo contrast and thromboembolism -
clinical implication 
 Previous reports suggested that the presence of 
LASEC was considered as a warning sign of left atrial 
thrombus and would be an indicator of increased risk 
of embolism.')') This hypothesis is based on the rela-
tively high incidence of left atrial thrombus and arte-
rial embolization in those patients. Erbel et al reported 
that cerebral and other peripheral embolism were 
found in 8 of 9 patients with spontaneous contrast."' 
In the series of Daniel et al, atrial thrombus or arterial 
embolization was found in 29 (48%) of 61 patients 
with spontaneous contrast in mitral valvular disease." 
 Our results indicated 8 (80%) of the 10 HCM pa-
tients in group 1 had LASEC, with a history of 
embolization in 3 (38%). The incidence of LASEC and 
the history of embolism were apparently high. Although 
the prognostic value may require further studies in 
large prospective trials, HCM patients with atrial fibril-
lation were strongly suggested to be in a high risk 
state of thromboembolism from our results. Identification
of high risk subpopulations in atrial fibrillation pa-
tients might be important to determine the indication 
of prophylactic anticoagulant therapy.
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